<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/qncx" ></link>
<id>urn:uuid:391ef34f-a8e6-8cd1-fa61-2493fc63ed48</id>
<updated>2026-07-26T20:51:21-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>QNCX: ROBERTS BRIGETTE (DIR) Filed a Form 3, Becoming a Registered Insider at QUINCE THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6424739" ></link>
<id>urn:uuid:a8b7d8de-62d9-bbfc-c5b6-6a5b0c058285</id>
<updated>2026-06-11T17:28:05-04:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: BENATTI LUCA (DIR) Sold (S) 50k Shares of QUINCE THERAPEUTICS INC for $3.47 on 12/26</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6298135" ></link>
<id>urn:uuid:9d207fb0-1f7c-c641-1792-bf63feb9ab26</id>
<updated>2025-12-29T17:36:12-05:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: BENATTI LUCA (DIR) Acquired (JB) 8,918 Shares of QUINCE THERAPEUTICS INC for $0.00 on 10/23</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6298130" ></link>
<id>urn:uuid:74fe19c9-a732-285d-3833-df86cb12c2d4</id>
<updated>2025-12-29T17:34:30-05:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: THYE DIRK (CEO,SO,DIR) Acquired (JB) 739,885 Shares of QUINCE THERAPEUTICS INC for $0.00 on 12/10</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6291879" ></link>
<id>urn:uuid:a8f360f5-39cc-024a-a080-d2847938360f</id>
<updated>2025-12-12T17:07:23-05:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: THYE DIRK (CEO,SO,DIR) Disposed (JS) 739,885 Shares of QUINCE THERAPEUTICS INC for $0.00 on 12/10</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6291880" ></link>
<id>urn:uuid:ce5f55fc-5a13-f8f8-bc86-981853259f19</id>
<updated>2025-12-12T17:07:23-05:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: HANNAH BRENDAN (COO,CCO) Exercised 27,551 Options (OB) of QUINCE THERAPEUTICS INC for $0.55-$0.94 on 12/5, and Kept Them All</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6287817" ></link>
<id>urn:uuid:9ad92042-6f11-a33c-5f80-2b7a4b59c99d</id>
<updated>2025-12-08T08:12:05-05:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: HANNAH BRENDAN (COO,CCO) Acquired (JB) 37,736 Shares of QUINCE THERAPEUTICS INC for $1.20 on 6/18</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6219776" ></link>
<id>urn:uuid:a53e342c-5df8-5941-57bd-78cbfb044937</id>
<updated>2025-06-23T08:48:00-04:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: RYAN CHARLES S (PR) Acquired (JB) 7,548 Shares of QUINCE THERAPEUTICS INC for $1.20 on 6/18</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6219775" ></link>
<id>urn:uuid:d2be9def-c4f2-1a89-7fe2-277f125ff2e3</id>
<updated>2025-06-23T08:46:04-04:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: THYE DIRK (CEO,SO,DIR) Acquired (JB) 150,944 Shares of QUINCE THERAPEUTICS INC for $1.20 on 6/18</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6219774" ></link>
<id>urn:uuid:1d0d55c1-89d4-7dc7-48c2-2904d53b9e83</id>
<updated>2025-06-23T08:43:12-04:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
<entry>
<title>QNCX: THYE DIRK (CEO,DIR) Bought (B) 154,500 Shares of QUINCE THERAPEUTICS INC for $0.69-$0.70 on 8/29-8/30</title>
<link href="http://www.insiderinsights.com/company/qncx/quince-therapeutics-inc/id-6052070" ></link>
<id>urn:uuid:1ccc2bd9-d616-ce09-5426-683a2cf56adc</id>
<updated>2024-09-03T17:38:44-04:00</updated>
<summary type="html" ><![CDATA[QUINCE THERAPEUTICS INC (QNCX). Recent Price: $17.86. Mkt Cap:17.5mm. 10D Vol: 39,800]]></summary>
</entry>
</feed>